Labcorp Income from Continuous Operations 2010-2024 | LH

Labcorp income from continuous operations for the twelve months ending September 30, 2024 was $0.437B, a 14.92% decline year-over-year.

  • Labcorp annual income from continuous operations for 2023 was $0.38B, a 62.09% decline from 2022.
  • Labcorp annual income from continuous operations for 2022 was $1.004B, a 54.34% decline from 2021.
  • Labcorp annual income from continuous operations for 2021 was $2.198B, a 41.14% increase from 2020.

Labcorp Income from Continuous Operations 2010-2024 | LH

  • Labcorp annual income from continuous operations for 2023 was $0.38B, a 62.09% decline from 2022.
  • Labcorp annual income from continuous operations for 2022 was $1.004B, a 54.34% decline from 2021.
  • Labcorp annual income from continuous operations for 2021 was $2.198B, a 41.14% increase from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M